Aernoud Fiolet

401 List of publications Nidorf SM, Fiolet ATL, Mosterd A, Eikelboom JW, Schut A, Opstal TSJ, The SHK, Xu X-F, Ireland MA, Lenderink T, Latchem D, Hoogslag P, Jerzewski A, Nierop P, Whelan A, Hendriks R, Swart H, Schaap J, Kuijper AFM, van Hessen MWJ, Saklani P, Tan I, Thompson AG, Morton A, Judkins C, Bax WA, Dirksen M, Alings MMW, Hankey GJ, Budgeon CA, Tijssen JGP, Cornel JH, Thompson PL. Colchicine in Patients with Chronic Coronary Disease. New England Journal of Medicine . 2020;383:1838–47. Fiolet ATL, Silvis MJM, Opstal TSJ, Bax WA, van der Horst FAL, Mosterd A, de Kleijn D, Cornel JH. Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids,bloodcount and renal function inchronic coronaryarterydisease and elevated high-sensitivity C-reactive protein. PLOS ONE . 2020;15:e0237665. Opstal TSJ, Hoogeveen RM, Fiolet ATL, Silvis MJM, The SHK, Bax WA, de Kleijn DPV, Mosterd A, Stroes ESG, Cornel JH. Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy. Circulation . 2020;142:1996–8. Nidorf SM, Fiolet ATL, Abela GS. Viewing atherosclerosis through a crystal lens: How the evolving structure of cholesterol crystals in atherosclerotic plaque alters its stability. Journal of Clinical Lipidology . 2020;14:619–30. Silvis MJM, Demkes EJ, Fiolet ATL, Dekker M, Bosch L, van Hout GPJ, Timmers L, de Kleijn DP V. Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction. Journal of Cardiovascular Translational Research . 2020;14:23–34. Daey Ouwens IM, Fiolet ATL, Thijs RD, Koehler PJ, Verhoeven W. Neurosyphilis mimicking autoimmune encephalitis: A case report and review of the literature. Clinical Neuropsychiatry: Journal of Treatments Evaluation . 2020;17:175–80. Groeneveld SA, Jongejan N, De Winter BJSAAF, Fiolet ATL. Hacking into a pacemaker: Risks of “smart healthcare” devices. Nederlands Tijdschrift Voor Geneeskunde . 2019;163:D3690. Nidorf SM, Fiolet ATL, Eikelboom JW, Schut A, Opstal TSJ, BaxWA, Budgeon CA, TijssenJGP,MosterdA, Cornel JH,Thompson PL.The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics. American Heart Journal . 2019;218:46–56.